Abstract
Introduction:Optimal adherence to antiretroviral therapy (ART) is crucial to promoting maternal-infant health.Setting:Fourteen sites in 7 countries within sub-Saharan Africa and India.Methods:The multicomponent, open-label strategy PROMISE trial enrolled breastfeeding mother-infant pairs not meeting in-country criteria for maternal ART (mART) initiation in the postpartum component within 5 days of delivery. Randomization was to mART versus infant NVP (iNVP) prophylaxis. Infants in the mART arm also received 6 weeks of iNVP. Self-reported adherence was assessed in a secondary analysis. Time-to-event analyses were performed to explore the association between adherence and maternal viral load (mVL) in the mART arm.Results:Two thousand four hundred thirty-one mother-infant pairs were enrolled between 2011 and 2014; the baseline maternal median CD4 was 686 (IQR 553-869), and the median mVL was 322 copies/mL (IQR 40-1422). Self-reported adherence was lower in the mART arm compared with the iNVP arm (no missed doses within 4 weeks of all study visits: 66% vs 83%; within 2 weeks: 71% vs 85%; P < 0.0001). The iNVP adherence at week 6 was high in both arms: 97% in mART arm; 95% in iNVP arm. Time-to-event analyses showed that adherence to mART was associated with time to first mVL ≥400 copies/mL (P < 0.0001). Missing 1 full day of doses over 3 days was associated with a 66% risk of mVL ≥1000 copies/mL (HR: 1.66; 95% CI: 1.37, 1.99).Conclusions:Postpartum women were less adherent to their own ART than mothers providing their infant's nevirapine prophylaxis. The self-reported missed mART doses were associated with high mVL. Strategies to optimize postpartum mART adherence are urgently needed.Clinical Trial Number:ClinicalTrials.gov: NCT01061151; closed to follow-up.
Original language | English (US) |
---|---|
Pages (from-to) | 76-83 |
Number of pages | 8 |
Journal | Journal of Acquired Immune Deficiency Syndromes |
Volume | 92 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2023 |
Keywords
- ART adherence
- mART
- postpartum
- viral load
- women with HIV
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)